Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 10  •  04:00PM ET
3.41
Dollar change
+0.08
Percentage change
2.40
%
Feb 10, 8:07 AMButterfly Network announces its Butterfly iQ+/iQ3 and Compass AI ultrasound solution have achieved GovRAMP and TX-RAMP authorizations, enabling the company to offer its cloud services to U.S. state and local government agencies including Texas.
IndexRUT P/E- EPS (ttm)-0.33 Insider Own23.54% Shs Outstand226.11M Perf Week-13.23%
Market Cap861.37M Forward P/E- EPS next Y-0.16 Insider Trans-3.18% Shs Float193.15M Perf Month-15.59%
Enterprise Value738.17M PEG- EPS next Q-0.04 Inst Own38.72% Short Float12.03% Perf Quarter52.91%
Income-79.87M P/S9.74 EPS this Y19.54% Inst Trans-11.78% Short Ratio4.01 Perf Half Y150.74%
Sales88.45M P/B4.22 EPS next Y7.63% ROA-28.77% Short Interest23.23M Perf YTD-10.26%
Book/sh0.81 P/C5.97 EPS next 5Y16.26% ROE-41.42% 52W High5.03 -32.21% Perf Year-17.63%
Cash/sh0.57 P/FCF- EPS past 3/5Y-22.46% 66.40% ROIC-35.94% 52W Low1.32 158.33% Perf 3Y39.75%
Dividend Est.- EV/EBITDA- Sales past 3/5Y9.46% 15.41% Gross Margin43.24% Volatility8.39% 8.08% Perf 5Y-85.04%
Dividend TTM- EV/Sales8.35 EPS Y/Y TTM28.91% Oper. Margin-91.74% ATR (14)0.29 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.51 Sales Y/Y TTM16.04% Profit Margin-90.31% RSI (14)40.08 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.80 EPS Q/Q-69.56% SMA20-16.71% Beta2.28 Target Price5.06
Payout- Debt/Eq0.10 Sales Q/Q4.51% SMA50-8.85% Rel Volume0.58 Prev Close3.33
Employees190 LT Debt/Eq0.09 EarningsFeb 26 BMO SMA20037.44% Avg Volume5.79M Price3.41
IPOJul 13, 2020 Option/ShortYes / Yes EPS/Sales Surpr.7.19% 1.27% Trades Volume3,379,052 Change2.40%
Date Action Analyst Rating Change Price Target Change
Aug-01-25Downgrade Oppenheimer Outperform → Perform
Jul-01-25Initiated Craig Hallum Buy $3
Mar-17-25Initiated William Blair Outperform
Sep-10-24Initiated Lake Street Buy $3
Mar-29-23Initiated UBS Neutral $2.25
Nov-29-22Initiated Oppenheimer Outperform $4.50
Oct-04-22Initiated B. Riley Securities Buy $9.50
Dec-17-21Initiated UBS Neutral $7
Jun-21-21Initiated Cowen Outperform $20
Feb-10-26 09:47AM
08:01AM
Feb-03-26 08:01AM
Jan-27-26 10:14AM
Jan-21-26 08:45AM
11:56AM Loading…
Jan-16-26 11:56AM
Jan-14-26 09:40AM
Jan-12-26 08:01AM
Jan-07-26 12:24PM
Jan-06-26 08:05AM
Dec-31-25 09:36AM
Dec-18-25 08:05AM
Dec-11-25 11:40PM
Dec-09-25 09:45AM
Nov-26-25 03:34PM
07:53AM Loading…
Nov-24-25 07:53AM
Nov-21-25 08:05AM
Nov-20-25 01:27AM
Nov-18-25 11:39AM
Nov-17-25 08:05AM
Oct-31-25 03:02PM
11:05AM
06:30AM
Oct-30-25 09:33AM
Oct-29-25 08:05AM
Oct-27-25 08:05AM
Oct-23-25 08:30AM
Oct-22-25 09:20AM
Oct-17-25 08:05AM
Oct-10-25 08:44AM
04:05PM Loading…
Oct-09-25 04:05PM
Oct-06-25 09:17AM
07:45AM
Oct-03-25 09:06AM
Sep-21-25 09:15AM
Sep-18-25 04:05PM
Sep-17-25 02:18PM
Sep-12-25 03:35AM
Sep-11-25 03:00PM
Sep-09-25 08:00AM
Sep-05-25 02:11PM
Aug-26-25 08:54AM
Aug-25-25 03:00PM
Aug-19-25 08:05AM
Aug-17-25 11:41PM
Aug-13-25 12:08PM
Aug-12-25 09:51PM
11:09AM
Aug-06-25 12:00PM
Aug-05-25 08:05AM
Aug-02-25 03:06AM
Aug-01-25 07:47AM
07:40AM
06:30AM
Jul-31-25 09:30AM
Jul-18-25 08:05AM
Jul-15-25 09:00AM
Jul-02-25 10:07PM
Jun-09-25 08:00AM
Jun-04-25 02:36PM
May-27-25 09:45AM
May-26-25 03:00PM
May-22-25 08:05AM
May-09-25 04:12AM
May-05-25 02:18PM
May-02-25 12:00PM
07:40AM
06:30AM
Apr-22-25 06:47PM
08:39AM
Apr-21-25 05:38AM
Apr-17-25 04:05PM
Apr-10-25 03:00PM
Apr-02-25 08:01AM
Mar-27-25 09:35AM
Mar-05-25 08:05AM
Feb-28-25 06:30AM
Feb-22-25 05:27PM
Feb-21-25 08:05AM
Feb-18-25 08:05AM
Jan-29-25 09:10PM
04:01PM
Jan-24-25 07:53PM
Jan-17-25 05:58PM
Jan-13-25 08:05AM
Jan-08-25 07:00AM
Dec-16-24 08:05AM
Dec-12-24 11:23AM
Nov-11-24 08:05AM
Nov-08-24 10:25AM
Nov-07-24 08:05AM
Nov-01-24 06:30AM
Oct-28-24 08:00AM
Oct-18-24 08:05AM
Oct-08-24 11:11AM
Sep-17-24 08:00AM
Sep-09-24 10:07AM
Sep-04-24 10:08AM
08:30AM
Sep-03-24 04:30PM
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Doherty John N.EVP, CFOJan 07 '26Sale3.9860,182239,5241,234,688Jan 09 04:02 PM
ROTHBERG JONATHAN MDirectorJan 07 '26Sale4.14452,7291,874,253335,834Jan 08 06:14 PM
ROTHBERG JONATHAN MDirectorJan 06 '26Sale4.03351,6171,416,806788,563Jan 08 06:14 PM
ROTHBERG JONATHAN MDirectorJan 08 '26Sale4.18335,8341,404,5250Jan 08 06:14 PM
ROTHBERG JONATHAN MDirectorJan 08 '26Proposed Sale4.18335,8341,404,525Jan 08 04:53 PM
ROTHBERG JONATHAN MDirectorJan 07 '26Proposed Sale4.14452,7291,874,253Jan 07 04:49 PM
Ku VictorChief Technology OfficerJan 05 '26Sale3.8235,968137,398811,962Jan 07 04:06 PM
Doherty John N.OfficerJan 07 '26Proposed Sale3.9860,182239,494Jan 07 03:13 PM
ROTHBERG JONATHAN MDirectorJan 06 '26Proposed Sale4.03351,6171,416,805Jan 06 05:22 PM
Ku VictorOfficerJan 05 '26Proposed Sale3.8235,968137,416Jan 05 03:11 PM
ROTHBERG JONATHAN MDirectorDec 23 '25Sale4.0144,781179,4241,157,764Dec 29 04:05 PM
ROTHBERG JONATHAN MDirectorDec 26 '25Sale4.0114,91159,7901,140,180Dec 29 04:05 PM
ROTHBERG JONATHAN MDirectorDec 24 '25Sale4.002,67310,6921,155,091Dec 29 04:05 PM
ROTHBERG JONATHAN MDirectorDec 26 '25Proposed Sale4.0114,91159,790Dec 29 02:52 PM
ROTHBERG JONATHAN MDirectorDec 24 '25Proposed Sale4.002,67310,692Dec 29 02:50 PM
ROTHBERG JONATHAN MDirectorDec 23 '25Proposed Sale4.0144,781179,424Dec 23 04:51 PM
ROTHBERG JONATHAN MDirectorDec 15 '25Sale3.16601,3081,902,659196,662Dec 17 05:56 PM
ROTHBERG JONATHAN MDirectorDec 16 '25Sale3.14284,986893,8300Dec 17 05:56 PM
Phanstiel S. LouiseDirectorDec 15 '25Buy3.08185,261571,160185,261Dec 17 04:10 PM
ROTHBERG JONATHAN MDirectorDec 16 '25Proposed Sale3.14284,986893,830Dec 16 04:41 PM
ROBBINS LARRYDirectorDec 11 '25Buy3.0221,37064,47114,335,055Dec 15 06:20 PM
ROTHBERG JONATHAN MDirectorDec 15 '25Proposed Sale3.16601,3081,902,658Dec 15 04:41 PM
ROTHBERG JONATHAN MDirectorDec 10 '25Sale3.13288,918905,238255,976Dec 12 06:58 PM
ROTHBERG JONATHAN MDirectorDec 12 '25Sale3.08193,293595,4200Dec 12 06:58 PM
ROTHBERG JONATHAN MDirectorDec 11 '25Sale3.08123,354380,128132,622Dec 12 06:58 PM
ROTHBERG JONATHAN MDirectorDec 12 '25Proposed Sale3.08193,293596,270Dec 12 04:56 PM
ROTHBERG JONATHAN MDirectorDec 11 '25Proposed Sale3.08123,354380,127Dec 11 04:50 PM
ROTHBERG JONATHAN MDirectorDec 08 '25Sale3.27769,3272,517,7760Dec 10 08:27 PM
ROTHBERG JONATHAN MDirectorDec 09 '25Sale3.11176,070546,768111,031Dec 10 08:27 PM
ROTHBERG JONATHAN MDirectorDec 10 '25Proposed Sale3.13288,918905,237Dec 10 05:19 PM
ROTHBERG JONATHAN MDirectorDec 09 '25Proposed Sale3.11176,070546,767Dec 09 05:07 PM
ROTHBERG JONATHAN MDirectorDec 04 '25Sale3.0864,198197,473581,199Dec 08 08:56 PM
ROTHBERG JONATHAN MDirectorDec 05 '25Sale3.0737,598115,591543,601Dec 08 08:56 PM
ROTHBERG JONATHAN MDirectorDec 08 '25Proposed Sale3.27769,3272,517,776Dec 08 06:03 PM
ROBBINS LARRYDirectorDec 03 '25Buy2.96821,6482,433,63913,576,792Dec 05 05:40 PM
ROBBINS LARRYDirectorDec 04 '25Buy2.99536,8931,607,83314,113,685Dec 05 05:40 PM
ROBBINS LARRYDirectorDec 05 '25Buy3.06200,000611,30014,313,685Dec 05 05:40 PM
ROTHBERG JONATHAN MDirectorDec 05 '25Proposed Sale3.0737,598115,591Dec 05 04:50 PM
ROTHBERG JONATHAN MDirectorDec 04 '25Proposed Sale3.0864,198197,473Dec 04 04:55 PM
Caezza NicholasDeputy General CounselDec 02 '25Sale2.831,6864,770231,035Dec 04 04:49 PM
ROTHBERG JONATHAN MDirectorNov 28 '25Sale3.08132,570408,183512,827Dec 02 05:58 PM
Caezza NicholasOfficerDec 02 '25Proposed Sale2.831,6864,769Dec 02 03:11 PM
ROTHBERG JONATHAN MDirectorNov 28 '25Proposed Sale3.08132,570408,196Nov 28 02:16 PM
ROTHBERG JONATHAN MDirectorNov 24 '25Sale3.151,110,5793,498,324769,814Nov 26 07:58 PM
ROTHBERG JONATHAN MDirectorNov 25 '25Sale3.27674,7582,206,459544,894Nov 26 07:58 PM
ROTHBERG JONATHAN MDirectorNov 26 '25Sale3.13442,5391,385,147797,970Nov 26 07:58 PM
ROTHBERG JONATHAN MDirectorNov 26 '25Proposed Sale3.13442,5391,383,598Nov 26 05:04 PM
ROTHBERG JONATHAN MDirectorNov 25 '25Proposed Sale3.27674,7582,206,729Nov 25 07:09 PM
ROTHBERG JONATHAN MDirectorNov 24 '25Proposed Sale3.151,110,5793,502,988Nov 24 06:39 PM
ROBBINS LARRYDirectorNov 20 '25Buy2.371,000,0002,366,00011,955,144Nov 21 05:35 PM
ROBBINS LARRYDirectorNov 19 '25Buy2.351,000,0002,353,90010,955,144Nov 21 05:35 PM
ROBBINS LARRYDirectorNov 21 '25Buy2.58800,0002,064,16012,755,144Nov 21 05:35 PM
ROTHBERG JONATHAN MDirectorNov 03 '25Sale3.08100,502309,3451,140,007Nov 05 04:04 PM
Carfora DawnDirectorNov 04 '25Sale2.69112,009301,864265,505Nov 05 04:04 PM
Carfora DawnDirectorNov 04 '25Proposed Sale2.69100,000269,140Nov 04 02:47 PM
Carfora DawnDirectorNov 04 '25Proposed Sale2.7612,00933,145Nov 04 01:06 PM
ROTHBERG JONATHAN MDirectorNov 03 '25Proposed Sale3.08100,502309,366Nov 03 06:15 PM
Cashman SteveChief Business OfficerSep 04 '25Sale1.50142,590214,3132,181,884Sep 08 04:57 PM
Carlson MeganInterim CFOSep 04 '25Sale1.5013,80320,746547,444Sep 08 04:56 PM
Caezza NicholasDeputy General CounselSep 03 '25Sale1.521,7242,622232,721Sep 05 04:40 PM
Carlson MeganOfficerSep 04 '25Proposed Sale1.5013,80320,740Sep 04 04:29 PM
Cashman SteveOfficerSep 04 '25Proposed Sale1.50142,590214,256Sep 04 04:19 PM
Caezza NicholasOfficerSep 03 '25Proposed Sale1.521,7242,622Sep 03 03:23 PM
Cashman SteveChief Business OfficerAug 25 '25Buy1.6450,00081,9532,324,474Aug 27 08:56 AM
Caezza NicholasDeputy General CounselAug 04 '25Sale1.453,1184,521234,445Aug 06 06:09 PM
Getz Heather CEVP, CFO & COOMay 05 '25Sale2.2065,456144,0692,919,274May 07 04:18 PM
Getz Heather COfficerMay 05 '25Proposed Sale2.2065,456144,062May 05 03:27 PM
DEVIVO JOSEPHPresident & CEOApr 25 '25Sale2.44320,215780,6847,249,789Apr 29 05:40 PM
DEVIVO JOSEPHOfficerApr 25 '25Proposed Sale2.44320,215780,716Apr 25 03:41 PM
Stoica Andrei GChief Technology OfficerApr 01 '25Sale2.171,8053,9081,600,182Apr 03 05:24 PM
Stoica Andrei GOfficerApr 01 '25Proposed Sale2.171,8053,908Apr 01 03:25 PM
Stoica Andrei GChief Technology OfficerMar 26 '25Sale2.693,3549,0161,601,987Mar 28 04:26 PM
Stoica Andrei GOfficerMar 26 '25Proposed Sale2.693,3549,017Mar 26 03:17 PM
Last Close
Feb 10  •  04:00PM ET
79.22
Dollar change
+0.14
Percentage change
0.18
%
GEHC GE HealthCare Technologies Inc daily Stock Chart
IndexNDX, S&P 500 P/E17.39 EPS (ttm)4.55 Insider Own0.27% Shs Outstand455.74M Perf Week0.56%
Market Cap36.10B Forward P/E14.16 EPS next Y5.59 Insider Trans0.00% Shs Float454.50M Perf Month-9.23%
Enterprise Value42.28B PEG1.32 EPS next Q1.05 Inst Own85.90% Short Float2.19% Perf Quarter8.45%
Income2.08B P/S1.75 EPS this Y10.15% Inst Trans0.07% Short Ratio2.78 Perf Half Y8.52%
Sales20.62B P/B3.48 EPS next Y10.62% ROA5.96% Short Interest9.97M Perf YTD-3.41%
Book/sh22.77 P/C8.00 EPS next 5Y10.71% ROE22.15% 52W High94.80 -16.43% Perf Year-9.46%
Cash/sh9.90 P/FCF23.99 EPS past 3/5Y2.53% 0.61% ROIC10.32% 52W Low57.65 37.42% Perf 3Y14.41%
Dividend Est.0.14 (0.18%) EV/EBITDA12.18 Sales past 3/5Y3.99% 3.74% Gross Margin39.70% Volatility3.78% 2.66% Perf 5Y-
Dividend TTM0.14 (0.18%) EV/Sales2.05 EPS Y/Y TTM4.69% Oper. Margin14.03% ATR (14)2.32 Perf 10Y-
Dividend Ex-DateJan 09, 2026 Quick Ratio1.08 Sales Y/Y TTM4.85% Profit Margin10.11% RSI (14)43.84 Recom1.88
Dividend Gr. 3/5Y- - Current Ratio1.33 EPS Q/Q-17.95% SMA20-1.97% Beta1.23 Target Price93.22
Payout3.08% Debt/Eq1.01 Sales Q/Q7.13% SMA50-4.04% Rel Volume1.08 Prev Close79.08
Employees54000 LT Debt/Eq0.95 EarningsFeb 04 BMO SMA2004.32% Avg Volume3.58M Price79.22
IPODec 15, 2022 Option/ShortYes / Yes EPS/Sales Surpr.2.97% 1.51% Trades Volume3,867,464 Change0.18%
Date Action Analyst Rating Change Price Target Change
Jan-15-26Downgrade UBS Neutral → Sell $77
Oct-13-25Initiated Barclays Equal Weight $86
Oct-07-25Downgrade Citigroup Buy → Neutral $83
May-05-25Upgrade UBS Sell → Neutral $73
Mar-11-25Upgrade Goldman Neutral → Buy $85 → $100
Jan-08-25Upgrade Jefferies Hold → Buy $95 → $103
Sep-26-24Downgrade UBS Neutral → Sell $84 → $74
Sep-18-24Upgrade BTIG Research Neutral → Buy $100
Sep-09-24Initiated JP Morgan Neutral $90
Aug-06-24Initiated Stifel Buy $100
Feb-10-26 12:20PM
Feb-09-26 12:06PM
10:40AM
08:00AM
Feb-06-26 08:53AM
07:05AM Loading…
07:05AM
Feb-05-26 12:44PM
09:00AM
12:35AM
Feb-04-26 04:26PM
04:02PM
01:38PM
01:20PM
11:03AM
10:12AM
10:10AM Loading…
10:10AM
09:42AM
09:30AM
07:30AM
07:03AM
07:01AM
06:46AM
06:36AM
06:35AM
06:20AM
Feb-03-26 01:13PM
11:31AM
Feb-02-26 10:11PM
09:40AM
09:15AM
08:29AM Loading…
08:29AM
08:00AM
Jan-30-26 02:31PM
Jan-25-26 10:31PM
Jan-22-26 11:38PM
03:09AM
Jan-19-26 08:46AM
Jan-16-26 11:56AM
Jan-15-26 04:33PM
01:31PM
11:09AM
09:53AM
09:36AM
08:17AM
06:03AM
Jan-14-26 12:21PM
09:40AM
07:46AM
Jan-12-26 09:30AM
07:51AM
Jan-11-26 11:01AM
Jan-09-26 04:52PM
09:34AM
Jan-08-26 07:41AM
Jan-06-26 05:00PM
08:17AM
06:08AM
Jan-05-26 08:00AM
Dec-31-25 11:38PM
Dec-30-25 09:30AM
07:32AM
Dec-29-25 08:00AM
Dec-28-25 06:00AM
Dec-19-25 09:30AM
Dec-17-25 12:02PM
08:26AM
Dec-16-25 09:00PM
08:13AM
Dec-15-25 09:40AM
Dec-12-25 04:42PM
03:23PM
Dec-11-25 07:10AM
Dec-09-25 11:47AM
11:32AM
Dec-08-25 09:39AM
09:30AM
Dec-05-25 11:47AM
09:13AM
Dec-04-25 11:30AM
Dec-03-25 01:00PM
09:00AM
Dec-02-25 12:49PM
09:00AM
07:56AM
Dec-01-25 11:47AM
09:00AM
Nov-30-25 10:00AM
09:00AM
Nov-28-25 11:30AM
09:50AM
Nov-26-25 09:09AM
08:18AM
07:59AM
Nov-25-25 09:30AM
09:00AM
08:22AM
Nov-24-25 05:15PM
02:15PM
11:09AM
08:12AM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kenneth StacherskiFormer OfficerNov 24 '25Proposed Sale77.004,585353,045Nov 24 04:24 PM
Kenneth StacherskiFormer OfficerOct 27 '25Proposed Sale78.954,585361,993Oct 27 04:26 PM
Kenneth StacherskiFormer OfficerSep 22 '25Proposed Sale74.4619,5241,453,773Sep 22 04:44 PM
Kenneth StacherskiFormer OfficerSep 12 '25Proposed Sale77.0311,757905,590Sep 12 04:47 PM
Rott RolandCEO, ImagingSep 11 '25Option Exercise55.915,341298,59232,128Sep 12 04:05 PM
Newcomb George A.Chief Accounting OfficerFeb 18 '25Sale92.542,000185,0807,462Feb 19 04:07 PM
Last Close
Feb 10  •  04:00PM ET
75.15
Dollar change
+0.13
Percentage change
0.17
%
HOLX Hologic, Inc daily Stock Chart
IndexS&P 500 P/E31.18 EPS (ttm)2.41 Insider Own1.52% Shs Outstand223.07M Perf Week0.70%
Market Cap16.78B Forward P/E15.39 EPS next Y4.88 Insider Trans-4.12% Shs Float219.86M Perf Month0.37%
Enterprise Value16.93B PEG1.97 EPS next Q1.07 Inst Own95.99% Short Float1.89% Perf Quarter1.42%
Income543.90M P/S4.07 EPS this Y4.68% Inst Trans-4.32% Short Ratio1.49 Perf Half Y10.53%
Sales4.13B P/B3.20 EPS next Y9.47% ROA6.07% Short Interest4.15M Perf YTD0.89%
Book/sh23.51 P/C7.09 EPS next 5Y7.83% ROE10.86% 52W High75.36 -0.28% Perf Year15.19%
Cash/sh10.59 P/FCF17.53 EPS past 3/5Y-21.45% -10.02% ROIC7.01% 52W Low51.90 44.80% Perf 3Y-8.20%
Dividend Est.- EV/EBITDA13.42 Sales past 3/5Y-5.53% 1.66% Gross Margin55.62% Volatility0.31% 0.31% Perf 5Y-5.59%
Dividend TTM- EV/Sales4.10 EPS Y/Y TTM-23.89% Oper. Margin23.66% ATR (14)0.26 Perf 10Y129.19%
Dividend Ex-Date- Quick Ratio3.32 Sales Y/Y TTM2.17% Profit Margin13.18% RSI (14)59.92 Recom3.06
Dividend Gr. 3/5Y- - Current Ratio4.04 EPS Q/Q-8.44% SMA200.23% Beta0.73 Target Price76.50
Payout0.00% Debt/Eq0.48 Sales Q/Q2.54% SMA500.35% Rel Volume0.64 Prev Close75.02
Employees7070 LT Debt/Eq0.48 EarningsJan 29 AMC SMA20010.00% Avg Volume2.79M Price75.15
IPOMar 01, 1990 Option/ShortYes / Yes EPS/Sales Surpr.-5.08% -2.20% Trades Volume1,792,530 Change0.17%
Date Action Analyst Rating Change Price Target Change
Jan-12-26Downgrade Argus Buy → Hold
Jan-05-26Downgrade Evercore ISI Outperform → In-line $78
Nov-21-25Downgrade BNP Paribas Exane Outperform → Neutral $79
Oct-07-25Upgrade Evercore ISI In-line → Outperform $78
Aug-18-25Upgrade Argus Hold → Buy $80
Aug-06-25Upgrade RBC Capital Mkts Sector Perform → Outperform $87
Jul-09-25Upgrade Citigroup Neutral → Buy $80
May-27-25Reiterated Needham Hold
Mar-03-25Downgrade Argus Buy → Hold
Feb-06-25Downgrade Leerink Partners Outperform → Market Perform $80 → $75
Feb-10-26 08:57AM
Feb-06-26 11:45AM
Feb-04-26 08:15AM
Feb-03-26 01:02PM
Feb-02-26 09:15AM
09:00AM Loading…
09:00AM
Jan-30-26 08:28AM
Jan-29-26 08:42PM
06:00PM
05:25PM
04:19PM
04:11PM
04:02PM
12:51PM
Jan-28-26 08:24AM
06:46AM Loading…
06:46AM
Jan-27-26 10:10PM
Jan-26-26 09:15AM
Jan-23-26 04:20PM
08:48AM
Jan-22-26 10:00AM
08:55AM
08:50AM
Jan-21-26 12:10PM
09:50AM
08:55AM
07:51AM
Jan-20-26 11:34PM
Jan-19-26 06:02PM
07:52AM
11:56AM Loading…
Jan-16-26 11:56AM
09:00AM
07:18AM
Jan-15-26 11:37PM
Jan-13-26 09:00AM
Jan-10-26 03:00PM
Jan-09-26 09:40AM
Jan-08-26 11:51AM
11:40AM
06:44AM
Jan-07-26 11:40AM
Jan-06-26 11:40AM
08:17AM
Jan-05-26 07:17AM
Dec-31-25 08:55AM
07:25AM
Dec-26-25 07:53AM
Dec-24-25 10:31PM
Dec-23-25 06:56PM
09:00AM
Dec-22-25 07:58AM
Dec-18-25 09:40AM
Dec-17-25 12:01PM
09:50AM
08:26AM
Dec-12-25 09:00AM
07:34AM
04:04AM
Dec-11-25 08:54PM
Dec-08-25 09:19AM
Dec-07-25 11:37PM
Dec-06-25 01:25PM
Dec-04-25 10:23AM
Dec-03-25 12:45PM
11:30AM
Dec-02-25 08:10AM
Dec-01-25 09:50AM
09:00AM
Nov-27-25 08:23AM
Nov-26-25 09:40AM
08:18AM
Nov-25-25 08:08AM
Nov-21-25 09:10AM
07:13AM
Nov-20-25 09:31AM
Nov-19-25 11:02PM
Nov-18-25 09:29AM
09:00AM
Nov-14-25 04:01PM
03:19PM
Nov-13-25 08:49AM
Nov-12-25 09:50AM
08:11AM
Nov-11-25 11:41AM
Nov-10-25 09:40AM
Nov-07-25 04:36PM
09:00AM
07:37AM
Nov-04-25 08:07AM
Nov-03-25 06:45PM
05:30PM
05:15PM
04:28PM
04:22PM
04:01PM
Nov-01-25 11:06PM
Oct-30-25 12:25PM
09:06AM
Oct-29-25 09:15AM
Oct-28-25 10:00AM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stamoulis ChristianaDirectorOct 20 '25Option Exercise36.047,402266,76854,738Oct 22 04:17 PM
Stamoulis ChristianaDirectorOct 20 '25Sale73.077,402540,86447,336Oct 22 04:17 PM
Stamoulis ChristianaDirectorOct 20 '25Proposed Sale73.077,402540,864Oct 20 10:12 AM
MACMILLAN STEPHEN PChairman, President and CEOSep 22 '25Option Exercise39.96138,3585,528,7861,372,982Sep 23 04:10 PM
MACMILLAN STEPHEN PChairman, President and CEOSep 22 '25Sale66.97138,3589,266,1181,234,624Sep 23 04:10 PM
MACMILLAN STEPHEN POfficerSep 22 '25Proposed Sale66.98138,3589,266,548Sep 22 04:25 PM
Madaus Martin DDirectorMay 07 '25Buy55.245,445300,7605,445May 09 04:39 PM